Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous acetaminophen for patent ductus arteriosus closure in preterm neonates
IRCT20190505043478N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Closure of the ductus arteriosus. Started Apr 2019; status: completed.
02
Drugs
acetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20190505043478N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190505043478N1.